James Agalloco


Since the formation of Agalloco & Associates in 1991, Jim has assisted more than 200 healthcare firms in a wide range of validation, aseptic processing, sterilization, and compliance areas. Jim has over 45 years of industry experience. He has worked in organic synthesis, pharmaceutical formulation, pharmaceutical production, project and process engineering, and validation during his career at Merck, Pfizer, Squibb and Bristol-Myers Squibb. Jim is a past President and Director of PDA. He is a member of USP’s Microbiology Expert Committee for 2005-2020. He has authored or co-authored more than 40 book chapters, over 110 papers and lectured extensively on sterilization, aseptic processing and process validation for PDA, ISPE, PhRMA, and other organizations, domestically and internationally. He is co-editor of Validation of Pharmaceutical Processes and Advanced Aseptic Processing Technology.




Rifat Atun, MBBS MBA DIC FRCGP FFPH FRCP


Dr. Atun is Professor of Global Health Systems at Harvard University, where he is the Director of Global Health Systems Cluster at Harvard University’s School of Public Health. From 2006 to 2013, Dr. Atun was Professor of International Health Management and Head of the Health Management Group at Imperial College London. He is an honorary professor at the London School of Hygiene and Tropical Medicine. Dr. Atun has worked extensively with the World Bank, World Health Organization, and the U.K. Department for International Development on design, implementation, and evaluation of health system reform programs in more than 20 countries. Between 2008 and 2012, he was a member of the Executive Management Team of The Global Fund to Fight AIDS, Tuberculosis, and Malaria as the Director of Strategy, Performance and Evaluation Cluster. He was a member of the Strategic Technical Advisory Group of the World Health Organization for Tuberculosis and chaired the WHO Task Force on Health Systems and Tuberculosis Control. From 2009 to 2012, he was the Chair of the STOP TB Partnership Coordinating Board. Between 2006 and 2008, he was a Member of the Advisory Committee for WHO Research Centre for Health Development in Japan. Dr. Atun is a member of the MRC Global Health Group as the MRC Infections and Immunity Board representative. He serves as a member of the PEPFAR Scientific Advisory Board, a member of the Norwegian Research Council’s Global Health and Vaccination Research (GLOBVAC) Board, a member of the Advisory Board for Merck for Mothers and a member of the Research Advisory Committee for the Public Health Foundation of India. Dr. Atun is a Fellow of the Royal College of General Practitioners, Fellow of the Faculty of Public Health of the Royal College of Physicians, and a Fellow of the Royal College of Physicians U.K. He studied medicine at University of London as a Commonwealth Scholar and completed his postgraduate medical studies and Masters in Business Administration at University of London and Imperial College London.




Kevin Barnes


Kevin Barnes is a serial entrepreneur who has brought to market hundreds of diverse products with particular expertise and experience in the medial and biomedical markets. He has run R&D division for MA Bioproducts and KPL and developed and brought online large production facilities spanning multiple locations with around the clock production. His passion lies in combining leading-edge science with focused design and best manufacturing practices. Managing operations, cGMP manufacturing, quality and engineering departments he has lead teams in the development and production of DNA sequencers, protein purification systems, profusion bioreactors, PCR cabinets, precision dispensing systems, and electrocauterizing surgical instruments.




Elizabeth Birch


Elizabeth Birch has had an extensive career that spans the corporate, legal, public policy, and nonprofit worlds. From heading litigation at Apple Computer, Inc. to playing a critical role in advancing LGBT rights at the helm of the Human Rights Campaign, Birch is known for her ability to lead teams to extraordinary achievement. She has advised leaders from U.S. presidents, members of Congress, and the Chairman of the Joint Chiefs of Staff to corporate CEOs and nonprofit/association leaders. She graduated from the University of Santa Clara School of Law in California and clerked at the California Supreme Court. Later, she was presented with a Ph.D. in Humanities from the University of Hawaii for her contributions to the civil rights movement in America. In 1995, Elizabeth moved to Washington, D.C. to head the Human Rights Campaign, the nation’s largest LGBT advocacy organization. Elizabeth is a well-known leader on Capitol Hill, at the White House, and among progressive leaders. She has advised the Clinton and Obama administrations, members of Congress, and the Pentagon. She has used her extensive experience to counsel corporations on issues of engagement, talent, diversity, inclusion, and how to drive better results through inspiration and great environmental design. Included in her extensive client list are: American Airlines, McDonald's, IBM, Intel, Cisco, General Mills, Google, Nationwide, Deloitte, U.S. Department of Defense, U.S. Navy, Mass Mutual, Visa, Cardinal Health, and Kaiser Permanente.




Winthrop Hallowell Churchill Jr., MD


Dr. Churchill is an Associate Professor at Harvard Medical School and a specialist in hematology at Boston’s Brigham and Women’s Hospital. He is Board Certified in internal medicine, immunology, and blood banking/transfusion medicine. His clinical interests are general hematology, transfusion medication, and hemolytic anemia. Dr. Churchill is also a member of the faculty of the Harvard-MIT Division of Health Sciences and Technology. He is a graduate of Columbia University’s College of Physicians and Surgeons. Dr. Churchill did his residency in internal medicine at Massachusetts General Hospital, with fellowships in immunology at the National Cancer Institute and Medicine at Peter Bent Brigham Hospitals.




Laura S. L. Herman, MBA MA


With nearly 20 years in management consulting and leading FSG's global health practice, Ms. Herman is VP of Strategy and Advocacy for the base of the pyramid business at Essilor, the world's largest manufacturer of eye glasses. Ms. Herman has led research for the UN’s Every Woman Every Child and Partnership for Maternal Newborn and Child Health groups and authored a Private Sector Engagement Guide around the opportunities for business to realize commercial benefits by filling gaps in the continuum of care for these vulnerable populations. Ms. Herman is a member of the Board of Directors for VillageReach, the Private Sector Working Group for USAID’s Call to Action and a technical advisor to the Partnership for Maternal Newborn and Child Health and a member of the Council on Foreign Relations and an advisor to AshokaU. She holds an MBA with a certificate in Public Management from Stanford’s Graduate School of Business. She also holds an MA in International Policy from Stanford University and a BBA in International Business from the University of Michigan.




Patricia Hibberd, MD PhD


Dr. Hibberd is the Chief of the Division of Global Health at Massachusetts General Hospital, Professor of Pediatrics at Harvard Medical School, and Professor of Global Health at Harvard School of Public Health. She was the Founding Director and Head of the Clinical Research Program at Children’s Hospital Boston where she developed a Department with 45 faculty/staff that supported the clinical research mission of the hospital. At Tufts University, Dr. Hibberd was the founding Director and Head of the Clinical Research Institute and was appointed Professor of Medicine, Pediatrics and Public Health. In 2006, she was tapped by Tufts University School of Medicine to head up the Center for Global Health Research. Her work has included studies in the slums of Lima, Peru; studies on safe water to prevent childhood diarrhea in Benin and Tunisia and ongoing studies of cryptosporidial diarrhea in Vellore, India. Dr. Hibberd received her undergraduate degree in Biochemistry at King’s College, University of London followed by her Ph.D. degree in Information Science/Epidemiology. After her post-doctoral fellowship at the University of Leicester, she received her medical training and graduated from Harvard Medical School.




Ron Kaiser


Ron Kaiser has more than 35 years of experience in public and private finance, accounting and operations management and has served as CFO or CEO for companies in the information technology, life sciences, and high tech manufacturing sectors. Since 1981, he has served as CFO during six Initial Public Offerings, which raised over $400 million on vital valuations totaling over $1.7 billion. He has also served as CEO, CFO, and other executive officer roles during the development of more than a dozen companies, including the sale of 11 companies for amounts totaling $2.5 billion. Mr. Kaiser was featured in Tech Capital Magazine's January/February 1999 issue as one of the East Coast's Top CFOs. In 2001 he received the Northern Virginia Technology Council "CFO of the Year - Community Service Award". He is also the recipient of the 2014 "Hall of Fame Award" given by the NVTC and Regional Technologies Counsel. He has served as an instructor and seminar speaker for over 50 AICPA, state society, and professional programs on internal controls, organizational and analytical XBRL reporting. He is a NVTC FastTrack Coach and serves as a Board Member of the National Association of Corporate Advisors.




Jack Levine, DDS


Dr. Levine has a private dental practice in New Haven, CT, and has also been working with dentists in the developing world for the last twenty years. He is a Fellow in the International College of Dentists, the American College of Dentists, The Academy of General Dentists, and the Pierre Fauchard Academy. His travels for dentistry have taken him to Nepal, Peru, Jamaica, Uganda, Rwanda, Tanzania, Kenya. He is currently the Program Director for the Health Volunteers Overseas dental project in Haiti. Dr. Levine received his Doctor of Dental Surgery degree from Temple University School of Dentistry and studied at the L.D. Pankey Institute for Advanced Dental Education.




Donald MacDonald, MD


Dr. MacDonald is an ophthalmologist at MonMouth Eyecare in New Jersey. He has performed not only thousands of LASIK and PRK surgeries over the last 15 years, but over 10,000 cataract surgeries over the past 25 years. As part of Right to Sight and Health, he has participated in many humanitarian missions to the Philippines, Nicaragua, Ghana, Cameroon, Rwanda, Senegal, and Tanzania, restoring vision to thousands of blind people who have no access to health care, as well as performing many eye plastic surgeries. He has served as a Trustee of the Monmouth County Volunteers, Rumson Country Day School, The ALS Foundation of NY and the Carter Burden Center for the Aging. He graduated Cum Laude from Portsmouth Abbey School, Williams College with Highest Honors in Chemistry and Dartmouth Medical School. He completed his residency at the Manhattan Eye, Ear, Nose and Throat Hospital and his Fellowship in Eye Plastic and Reconstructive Surgery at both the New York Eye and Ear Infirmary and the Manhattan Eye, Ear, Nose and Throat Hospital.




Hiep Nguyen, MD


Dr. Hiep Nguyen is an Associate Professor in Surgery (Urology) at Harvard Medical School and an attending urologist at Children’s Hospital Boston. He is the director of the Robotic Surgery, Research, and Training Center and the Pediatric TeleUrology Service at Children’s Hospital Boston. Dr. Nguyen is a surgeon-scientist; his focus is on patient care, research and teaching of congenital and acquired disorders of the genitourinary tract in children. He has a long-standing interest in the application of modern technology to health care. He is working with colleagues at CHB, other academic institutions, and industries to design the next generation robotic instruments and devices. As the Rose Zimmerman Mandell Chair in Innovative Urological Technology, Dr. Nguyen is working to incorporate novel technology into daily medical and surgical practice. One of his principal interests is in international health. Dr. Nguyen has been a volunteer and board member for IVUmed for over 12 years. He is also the technology and educational chairperson for Boston Children’s Hospital International Health Center and the Center for Global Health. Dr. Nguyen graduated from the University of California at Davis with a BS in Biochemistry. He then went on to complete medical school and his urology residency at the University of California San Francisco, followed by a fellowship in Pediatric Urology at Children’s Hospital Boston.




Sulayman S. Nyang, PhD


Dr. Nyang is the former professor and chairman of the African Studies Department at Howard University in Washington, D.C., and co-principal investigator of Project MAPS. A former deputy ambassador and head of the chancery of the Gambia Embassy in Jeddah, Saudi Arabia, he has served as consultant to several national and international agencies and on the boards of the African Studies Association, the American Council for the Study of Islamic Societies, America's Islamic Heritage Museum, and the Association of Muslim Social Scientists. Dr. Nyang has written extensively on Islamic, African and Middle Eastern affairs. He was an advising scholar for the award-winning, PBS-broadcast documentaries Muhammad: Legacy of a Prophet (2002) and Prince Among Slaves (2007), produced by Unity Productions Foundation. Dr. Nyang holds a master's degree in public administration and a Ph.D. in government from the University of Virginia.




David Opie, PhD


Dr. Opie, Senior Vice President, Research and Development, at Noxilizer, Inc., has extensive medical device development experience with both start-ups and industry leaders, including Johnson & Johnson and Cook Medical. He has numerous filed and issued patents and has commercialized technologies that are used in life-saving applications. He has experience with cardiovascular devices, implants, equipment design, and manufacturing, as well as drug delivery market segments. Dr. Opie has a thorough knowledge of product invention, of Good Laboratory Practices, Good Manufacturing Practices, and design control and product development procedures. Dr. Opie holds a Ph.D. and an M.S. in Physics from the College of William and Mary, and a B.A. in Physics from the University of Delaware.




Jonathan Prinz


Jonathan J Prinz began his professional life as a rabbi serving, along with his father, the country’s largest independent synagogue. During that time, he was active in the civil rights movement and was among the founders of the first Community Action Anti-Poverty program funded by the Equal Opportunity Act. After leaving the active rabbinate, and a brief period in politics, he spent nearly a decade on Wall Street where he was the communications officer for the firm led by the legendary Sanford I Weill. He then embarked upon a three-decade career in Corporate and Brand identity serving blue-chip clients. He was President and a principal of a firm that became part of the Omnicom Group and since 1995 has had his own consultancy practice, TransformationBranding. Beyond identity consulting, his time is primarily devoted to writing including his blog: Beyond All That focusing on current affairs, religion and politics. He is also written a book, Transcenders: Living beyond religion and the religious wars. After many years in New York City, he now lives and works in Chapel Hill, North Carolina. He has two grown sons.




Leland C. Stanford


Mr. Stanford is President-CEO of Leland Limited Incorporated, which manufactures millions of disposable gas filled cylinders and assembles and tests dozens of products for use in the aerospace, medical, beverage and safety industries. He pioneered the mini-cartridge over 10 years ago, which are now powering the FDA approved Auvi-Q self-injector for epinephrine (www.auvi-q.com). This breakthrough device is unique in many ways in that it ‘talks the patient through the drug delivery process’ and the device platform allows many existing drugs to be utilized, as reformulation is not needed, an issue in the needle-free market segment which also uses Leland’s gas technologies. He attended Gill St. Bernard’s College Preparatory School and received a BS from Farleigh Dickinson University. He also apprenticed for 12 years under Carl Sollmann, Supervising Engineer.




Linda L. Wright, MD – Former Senior Medical Officer, Office of the Director at NICHD, NIH


Dr. Linda L. Wright is a board-certified pediatrician and neonatologist and an adjunct professor at George Washington University. She recently retired from NICHD where she was the Deputy Director of the Center for Research for Mothers and Children and directed two large cooperative clinical research networks: the Neonatal Research Network and the Global Network for Women’s and Children’s Health Research. Under her leadership, the Neonatal Research Network became a major force in transforming neonatology into an evidence-based specialty with seminal trials in inhaled nitric oxide for respiratory failure, hypothermia for asphyxia, gentle ventilation to prevent chronic lung disease, and the first national follow-up program for extremely low-birth-weight babies. NIH’s most successful Consensus Development Conference, The Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes, was proposed and organized by Dr. Wright; it changed obstetric practice, increasing antenatal corticosteroid use for preterm delivery from 18 to 80%. Dr. Wright has been actively involved in more than 50 large randomized controlled trials and studies, published more than 190 research articles, and has collaborated with WHO, USAID, the Bill and Melinda Gates Foundation, AAP, ACOG, Laerdal Foundation, GAPPS, the UN Commission on Life-Saving Commodities for Women’s and Children’s Health, Jhpiego, IBP Contraception Consortium, PATH, Survive and Thrive, Johnson and Johnson, and other major groups involved in global health. She reviews for a number of important domestic and international journals. Her major research interests are improving the health of women and children in the developing world and building research capacity and infrastructure through collaborative research.





Board of Directors

Board of Advisors

James Agalloco


Since the formation of Agalloco & Associates in 1991, Jim has assisted more than 200 healthcare firms in a wide range of validation, aseptic processing, sterilization, and compliance areas. Jim has over 45 years of industry experience. He has worked in organic synthesis, pharmaceutical formulation, pharmaceutical production, project and process engineering, and validation during his career at Merck, Pfizer, Squibb and Bristol-Myers Squibb. Jim is a past President and Director of PDA. He is a member of USP’s Microbiology Expert Committee for 2005-2020. He has authored or co-authored more than 40 book chapters, over 110 papers and lectured extensively on sterilization, aseptic processing and process validation for PDA, ISPE, PhRMA, and other organizations, domestically and internationally. He is co-editor of Validation of Pharmaceutical Processes and Advanced Aseptic Processing Technology.




Rifat Atun, MBBS MBA DIC FRCGP FFPH FRCP


Dr. Atun is Professor of Global Health Systems at Harvard University, where he is the Director of Global Health Systems Cluster at Harvard University’s School of Public Health. From 2006 to 2013, Dr. Atun was Professor of International Health Management and Head of the Health Management Group at Imperial College London. He is an honorary professor at the London School of Hygiene and Tropical Medicine. Dr. Atun has worked extensively with the World Bank, World Health Organization, and the U.K. Department for International Development on design, implementation, and evaluation of health system reform programs in more than 20 countries. Between 2008 and 2012, he was a member of the Executive Management Team of The Global Fund to Fight AIDS, Tuberculosis, and Malaria as the Director of Strategy, Performance and Evaluation Cluster. He was a member of the Strategic Technical Advisory Group of the World Health Organization for Tuberculosis and chaired the WHO Task Force on Health Systems and Tuberculosis Control. From 2009 to 2012, he was the Chair of the STOP TB Partnership Coordinating Board. Between 2006 and 2008, he was a Member of the Advisory Committee for WHO Research Centre for Health Development in Japan. Dr. Atun is a member of the MRC Global Health Group as the MRC Infections and Immunity Board representative. He serves as a member of the PEPFAR Scientific Advisory Board, a member of the Norwegian Research Council’s Global Health and Vaccination Research (GLOBVAC) Board, a member of the Advisory Board for Merck for Mothers and a member of the Research Advisory Committee for the Public Health Foundation of India. Dr. Atun is a Fellow of the Royal College of General Practitioners, Fellow of the Faculty of Public Health of the Royal College of Physicians, and a Fellow of the Royal College of Physicians U.K. He studied medicine at University of London as a Commonwealth Scholar and completed his postgraduate medical studies and Masters in Business Administration at University of London and Imperial College London.




Kevin Barnes


Kevin Barnes is a serial entrepreneur who has brought to market hundreds of diverse products with particular expertise and experience in the medial and biomedical markets. He has run R&D division for MA Bioproducts and KPL and developed and brought online large production facilities spanning multiple locations with around the clock production. His passion lies in combining leading-edge science with focused design and best manufacturing practices. Managing operations, cGMP manufacturing, quality and engineering departments he has lead teams in the development and production of DNA sequencers, protein purification systems, profusion bioreactors, PCR cabinets, precision dispensing systems, and electrocauterizing surgical instruments.




Elizabeth Birch


Elizabeth Birch has had an extensive career that spans the corporate, legal, public policy, and nonprofit worlds. From heading litigation at Apple Computer, Inc. to playing a critical role in advancing LGBT rights at the helm of the Human Rights Campaign, Birch is known for her ability to lead teams to extraordinary achievement. She has advised leaders from U.S. presidents, members of Congress, and the Chairman of the Joint Chiefs of Staff to corporate CEOs and nonprofit/association leaders. She graduated from the University of Santa Clara School of Law in California and clerked at the California Supreme Court. Later, she was presented with a Ph.D. in Humanities from the University of Hawaii for her contributions to the civil rights movement in America. In 1995, Elizabeth moved to Washington, D.C. to head the Human Rights Campaign, the nation’s largest LGBT advocacy organization. Elizabeth is a well-known leader on Capitol Hill, at the White House, and among progressive leaders. She has advised the Clinton and Obama administrations, members of Congress, and the Pentagon. She has used her extensive experience to counsel corporations on issues of engagement, talent, diversity, inclusion, and how to drive better results through inspiration and great environmental design. Included in her extensive client list are: American Airlines, McDonald's, IBM, Intel, Cisco, General Mills, Google, Nationwide, Deloitte, U.S. Department of Defense, U.S. Navy, Mass Mutual, Visa, Cardinal Health, and Kaiser Permanente.




Winthrop Hallowell Churchill Jr., MD


Dr. Churchill is an Associate Professor at Harvard Medical School and a specialist in hematology at Boston’s Brigham and Women’s Hospital. He is Board Certified in internal medicine, immunology, and blood banking/transfusion medicine. His clinical interests are general hematology, transfusion medication, and hemolytic anemia. Dr. Churchill is also a member of the faculty of the Harvard-MIT Division of Health Sciences and Technology. He is a graduate of Columbia University’s College of Physicians and Surgeons. Dr. Churchill did his residency in internal medicine at Massachusetts General Hospital, with fellowships in immunology at the National Cancer Institute and Medicine at Peter Bent Brigham Hospitals.




Laura S. L. Herman, MBA MA


With nearly 20 years in management consulting and leading FSG's global health practice, Ms. Herman is VP of Strategy and Advocacy for the base of the pyramid business at Essilor, the world's largest manufacturer of eye glasses. Ms. Herman has led research for the UN’s Every Woman Every Child and Partnership for Maternal Newborn and Child Health groups and authored a Private Sector Engagement Guide around the opportunities for business to realize commercial benefits by filling gaps in the continuum of care for these vulnerable populations. Ms. Herman is a member of the Board of Directors for VillageReach, the Private Sector Working Group for USAID’s Call to Action and a technical advisor to the Partnership for Maternal Newborn and Child Health and a member of the Council on Foreign Relations and an advisor to AshokaU. She holds an MBA with a certificate in Public Management from Stanford’s Graduate School of Business. She also holds an MA in International Policy from Stanford University and a BBA in International Business from the University of Michigan.




Patricia Hibberd, MD PhD


Dr. Hibberd is the Chief of the Division of Global Health at Massachusetts General Hospital, Professor of Pediatrics at Harvard Medical School, and Professor of Global Health at Harvard School of Public Health. She was the Founding Director and Head of the Clinical Research Program at Children’s Hospital Boston where she developed a Department with 45 faculty/staff that supported the clinical research mission of the hospital. At Tufts University, Dr. Hibberd was the founding Director and Head of the Clinical Research Institute and was appointed Professor of Medicine, Pediatrics and Public Health. In 2006, she was tapped by Tufts University School of Medicine to head up the Center for Global Health Research. Her work has included studies in the slums of Lima, Peru; studies on safe water to prevent childhood diarrhea in Benin and Tunisia and ongoing studies of cryptosporidial diarrhea in Vellore, India. Dr. Hibberd received her undergraduate degree in Biochemistry at King’s College, University of London followed by her Ph.D. degree in Information Science/Epidemiology. After her post-doctoral fellowship at the University of Leicester, she received her medical training and graduated from Harvard Medical School.




Ron Kaiser


Ron Kaiser has more than 35 years of experience in public and private finance, accounting and operations management and has served as CFO or CEO for companies in the information technology, life sciences, and high tech manufacturing sectors. Since 1981, he has served as CFO during six Initial Public Offerings, which raised over $400 million on vital valuations totaling over $1.7 billion. He has also served as CEO, CFO, and other executive officer roles during the development of more than a dozen companies, including the sale of 11 companies for amounts totaling $2.5 billion. Mr. Kaiser was featured in Tech Capital Magazine's January/February 1999 issue as one of the East Coast's Top CFOs. In 2001 he received the Northern Virginia Technology Council "CFO of the Year - Community Service Award". He is also the recipient of the 2014 "Hall of Fame Award" given by the NVTC and Regional Technologies Counsel. He has served as an instructor and seminar speaker for over 50 AICPA, state society, and professional programs on internal controls, organizational and analytical XBRL reporting. He is a NVTC FastTrack Coach and serves as a Board Member of the National Association of Corporate Advisors.




Jack Levine, DDS


Dr. Levine has a private dental practice in New Haven, CT, and has also been working with dentists in the developing world for the last twenty years. He is a Fellow in the International College of Dentists, the American College of Dentists, The Academy of General Dentists, and the Pierre Fauchard Academy. His travels for dentistry have taken him to Nepal, Peru, Jamaica, Uganda, Rwanda, Tanzania, Kenya. He is currently the Program Director for the Health Volunteers Overseas dental project in Haiti. Dr. Levine received his Doctor of Dental Surgery degree from Temple University School of Dentistry and studied at the L.D. Pankey Institute for Advanced Dental Education.




Donald MacDonald, MD


Dr. MacDonald is an ophthalmologist at MonMouth Eyecare in New Jersey. He has performed not only thousands of LASIK and PRK surgeries over the last 15 years, but over 10,000 cataract surgeries over the past 25 years. As part of Right to Sight and Health, he has participated in many humanitarian missions to the Philippines, Nicaragua, Ghana, Cameroon, Rwanda, Senegal, and Tanzania, restoring vision to thousands of blind people who have no access to health care, as well as performing many eye plastic surgeries. He has served as a Trustee of the Monmouth County Volunteers, Rumson Country Day School, The ALS Foundation of NY and the Carter Burden Center for the Aging. He graduated Cum Laude from Portsmouth Abbey School, Williams College with Highest Honors in Chemistry and Dartmouth Medical School. He completed his residency at the Manhattan Eye, Ear, Nose and Throat Hospital and his Fellowship in Eye Plastic and Reconstructive Surgery at both the New York Eye and Ear Infirmary and the Manhattan Eye, Ear, Nose and Throat Hospital.




Hiep Nguyen, MD


Dr. Hiep Nguyen is an Associate Professor in Surgery (Urology) at Harvard Medical School and an attending urologist at Children’s Hospital Boston. He is the director of the Robotic Surgery, Research, and Training Center and the Pediatric TeleUrology Service at Children’s Hospital Boston. Dr. Nguyen is a surgeon-scientist; his focus is on patient care, research and teaching of congenital and acquired disorders of the genitourinary tract in children. He has a long-standing interest in the application of modern technology to health care. He is working with colleagues at CHB, other academic institutions, and industries to design the next generation robotic instruments and devices. As the Rose Zimmerman Mandell Chair in Innovative Urological Technology, Dr. Nguyen is working to incorporate novel technology into daily medical and surgical practice. One of his principal interests is in international health. Dr. Nguyen has been a volunteer and board member for IVUmed for over 12 years. He is also the technology and educational chairperson for Boston Children’s Hospital International Health Center and the Center for Global Health. Dr. Nguyen graduated from the University of California at Davis with a BS in Biochemistry. He then went on to complete medical school and his urology residency at the University of California San Francisco, followed by a fellowship in Pediatric Urology at Children’s Hospital Boston.




Sulayman S. Nyang, PhD


Dr. Nyang is the former professor and chairman of the African Studies Department at Howard University in Washington, D.C., and co-principal investigator of Project MAPS. A former deputy ambassador and head of the chancery of the Gambia Embassy in Jeddah, Saudi Arabia, he has served as consultant to several national and international agencies and on the boards of the African Studies Association, the American Council for the Study of Islamic Societies, America's Islamic Heritage Museum, and the Association of Muslim Social Scientists. Dr. Nyang has written extensively on Islamic, African and Middle Eastern affairs. He was an advising scholar for the award-winning, PBS-broadcast documentaries Muhammad: Legacy of a Prophet (2002) and Prince Among Slaves (2007), produced by Unity Productions Foundation. Dr. Nyang holds a master's degree in public administration and a Ph.D. in government from the University of Virginia.




David Opie, PhD


Dr. Opie, Senior Vice President, Research and Development, at Noxilizer, Inc., has extensive medical device development experience with both start-ups and industry leaders, including Johnson & Johnson and Cook Medical. He has numerous filed and issued patents and has commercialized technologies that are used in life-saving applications. He has experience with cardiovascular devices, implants, equipment design, and manufacturing, as well as drug delivery market segments. Dr. Opie has a thorough knowledge of product invention, of Good Laboratory Practices, Good Manufacturing Practices, and design control and product development procedures. Dr. Opie holds a Ph.D. and an M.S. in Physics from the College of William and Mary, and a B.A. in Physics from the University of Delaware.




Jonathan Prinz


Jonathan J Prinz began his professional life as a rabbi serving, along with his father, the country’s largest independent synagogue. During that time, he was active in the civil rights movement and was among the founders of the first Community Action Anti-Poverty program funded by the Equal Opportunity Act. After leaving the active rabbinate, and a brief period in politics, he spent nearly a decade on Wall Street where he was the communications officer for the firm led by the legendary Sanford I Weill. He then embarked upon a three-decade career in Corporate and Brand identity serving blue-chip clients. He was President and a principal of a firm that became part of the Omnicom Group and since 1995 has had his own consultancy practice, TransformationBranding. Beyond identity consulting, his time is primarily devoted to writing including his blog: Beyond All That focusing on current affairs, religion and politics. He is also written a book, Transcenders: Living beyond religion and the religious wars. After many years in New York City, he now lives and works in Chapel Hill, North Carolina. He has two grown sons.




Leland C. Stanford


Mr. Stanford is President-CEO of Leland Limited Incorporated, which manufactures millions of disposable gas filled cylinders and assembles and tests dozens of products for use in the aerospace, medical, beverage and safety industries. He pioneered the mini-cartridge over 10 years ago, which are now powering the FDA approved Auvi-Q self-injector for epinephrine (www.auvi-q.com). This breakthrough device is unique in many ways in that it ‘talks the patient through the drug delivery process’ and the device platform allows many existing drugs to be utilized, as reformulation is not needed, an issue in the needle-free market segment which also uses Leland’s gas technologies. He attended Gill St. Bernard’s College Preparatory School and received a BS from Farleigh Dickinson University. He also apprenticed for 12 years under Carl Sollmann, Supervising Engineer.




Linda L. Wright, MD – Former Senior Medical Officer, Office of the Director at NICHD, NIH


Dr. Linda L. Wright is a board-certified pediatrician and neonatologist and an adjunct professor at George Washington University. She recently retired from NICHD where she was the Deputy Director of the Center for Research for Mothers and Children and directed two large cooperative clinical research networks: the Neonatal Research Network and the Global Network for Women’s and Children’s Health Research. Under her leadership, the Neonatal Research Network became a major force in transforming neonatology into an evidence-based specialty with seminal trials in inhaled nitric oxide for respiratory failure, hypothermia for asphyxia, gentle ventilation to prevent chronic lung disease, and the first national follow-up program for extremely low-birth-weight babies. NIH’s most successful Consensus Development Conference, The Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes, was proposed and organized by Dr. Wright; it changed obstetric practice, increasing antenatal corticosteroid use for preterm delivery from 18 to 80%. Dr. Wright has been actively involved in more than 50 large randomized controlled trials and studies, published more than 190 research articles, and has collaborated with WHO, USAID, the Bill and Melinda Gates Foundation, AAP, ACOG, Laerdal Foundation, GAPPS, the UN Commission on Life-Saving Commodities for Women’s and Children’s Health, Jhpiego, IBP Contraception Consortium, PATH, Survive and Thrive, Johnson and Johnson, and other major groups involved in global health. She reviews for a number of important domestic and international journals. Her major research interests are improving the health of women and children in the developing world and building research capacity and infrastructure through collaborative research.





Eniware has assembled a group of experienced professionals who are leaders in their disciplines to advise and assist the company in its goal of developing and successfully introducing a portable sterilizer.